Table 1. Basic characteristics of CHD cases and healthy controls.
| Variables | Male | Female | ||||
|---|---|---|---|---|---|---|
| Case | Control | p | Case | Control | p | |
| Number | 291 | 385 | 165 | 300 | ||
| Age yr (mean ± sd) | 59.56±12.18 | 47.55±10.655 | < 0.001 | 64.01±10.74 | 49.93±7.743 | < 0.001 |
| ALB (g/L) | 40.86±4.50 | 41.13±0.30 | ||||
| ALB/GLOB | 1.66±0.26 | 1.59±0.01 | ||||
| ALT (U/L) | 32.32±34.17 | 29.09±4.61 | ||||
| AST (U/L) | 38.16±69.46 | 33.32±3.49 | ||||
| AST/ALT | 1.23±0.94 | 1.42±0.08 | ||||
| aPOA1 (g/L) | 1.22±0.24 | 1.33±0.02 | ||||
| aPOB (g/L) | 0.97±0.37 | 1.05±0.03 | ||||
| aPOA1/aPOB | 1.45±0.71 | 1.47±0.06 | ||||
| Ca(mmol/l) | 2.29±0.16 | 2.29±0.01 | ||||
| GGT (U/L) | 47.06±69.30 | 40.39±7.46 | ||||
| GLU (mmol/L) | 6.27±2.23 | 6.45±0.21 | ||||
| HDL-C (mmol/L) | 1.10±0.25 | 1.19±0.02 | ||||
| LDL-C (mmol/L) | 1.86±0.89 | 2.02±0.57 | ||||
| Lp(a) (mg/L) | 227.16±253.31 | 260.70±19.93 | ||||
| MPV (fl) | 13.27±7.29 | 12.75±0.59 | ||||
| PLT (109/L) | 163.19±72.13 | 180.38±0.29 | ||||
| PCT (%) | 1.25±3.45 | 0.94±0.22 | ||||
| PDW (%) | 14.32±2.79 | 14.07±0.26 | ||||
| TP(g/L) | 69.51±6.63 | 67.229±0.455 | ||||
| TG (mmol/L) | 1.80±1.65 | 1.80±0.10 | ||||
| TC (mmol/L) | 3.96±1.19 | 4.33±0.09 | ||||
| UA(umol/l) | 311.77±85.46 | 265.80±6.24 | ||||
ALB: albumin, ALB/GLOB: albumin/globulin, ALT: alanine aminotransferase, AST: aspartate aminotransferase, apoA: apolipoprotein A, apoB: apolipoprotein B, GGT: gamma-glutamyl transpeptidase, GLU: glucose, HDL: high-density lipoprotein, LDL: low-density lipoprotein, LP(a): lipoprotein, MPV: Mean Platelet Volume, PLT: platelet, PCT: plateletcrit, PDW: platelet distribution width, TP: total protein, TG: triglyceride, TC: total cholesterol, UA: Uric acid.
p values were calculated using the Welch's test; p < 0.001 indicates statistical significance.